HEMATOLOGY
August 19, 2019
Novel Therapies for Transthyretin Amyloidosis
Transthyretin amyloidosis is a progressive, multiorgan, multigenotypic disease caused by TTR amyloid fibril deposition in various tissues.February 15, 2019
Preventing Infection Post Hematopoietic Cell Transplantation
August 17, 2018
Sickle Cell Disease Pain Management
January 20, 2016
Recommended Doses of Hydroxyurea Increase Sickle Cell Survival
December 14, 2015
Drug-Induced Bleeding
December 14, 2015
FDA Approves Three New Treatments for Multiple Myeloma
July 20, 2015
Options in the Management of Sickle Cell Disease
August 20, 2014
Breakthrough Therapy Approved for Leukemia and Lymphoma
January 22, 2014
Multiple Myeloma: An Overview of the Disease and Treatment Options
Related CE
$6.97 Per CE Exam or $59 for 12 Lessons
Copyright © 2000 - 2019 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.